Compound Evidence File
#EC-2026-0829
Tren Hex
Filed under Injectable Oils. The bureau holds 144 laboratory returns for this compound from 58 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
58 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 17 Feb 2026 | 11 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Nov 2025 | 4 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Feb 2026 | 27 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 19 Apr 2026 | 19 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Apr 2026 | 18 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 7 Feb 2026 | 8 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Mar 2026 | 25 Apr 2026 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 | 27 Feb 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Jan 2026 | 27 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Mar 2026 | 7 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Jan 2026 | 9 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Feb 2026 | 13 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Mar 2026 | 16 Aug 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 9.9 | 2 May 2026 | 4 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 3 May 2026 | 16 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 9 May 2026 | 26 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Apr 2026 | 9 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 11 Apr 2026 | 3 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 9.9 | 14 Mar 2026 | 15 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 9.9 | 14 Jun 2026 | 24 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 9.9 | 8 Aug 2026 | 9 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Jun 2026 | 19 Jul 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 8.6 | 8.6 | 8.6 | 20 Jun 2025 | 20 Jun 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 1 | 8.5 | 8.5 | 8.5 | 21 May 2025 | 21 May 2025 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 8.5 | 8.5 | 8.5 | 6 May 2025 | 6 May 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.4 | 6.5 | 10.0 | 24 May 2026 | 24 May 2026 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 8.4 | 8.4 | 8.4 | 2 Apr 2025 | 2 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.3 | 7.5 | 8.8 | 21 May 2026 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 8.3 | 6.9 | 9.7 | 24 May 2026 | 24 May 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 8.3 | 8.3 | 8.3 | 2 Apr 2025 | 2 Apr 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.2 | 6.8 | 9.2 | 24 May 2026 | 24 May 2026 |
| HealthTide BiotechCASE #VI-2026-0955 | X | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 | 14 Jan 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.0 | 6.4 | 8.9 | 23 May 2026 | 23 May 2026 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 3 | 8.0 | 6.6 | 9.3 | 3 Jul 2025 | 24 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 | 8 Jul 2025 |
| Zztai PeptideCASE #VI-2026-0192 | C | 3 | 7.3 | 5.7 | 8.3 | 27 Feb 2025 | 21 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 7 | 7.2 | 5.3 | 9.4 | 28 Mar 2025 | 21 May 2026 |
| Verified PeptidesCASE #VI-2026-0407 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 | 13 Feb 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 7 | 6.8 | 5.7 | 8.2 | 7 May 2025 | 19 Jan 2026 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 6.8 | 6.8 | 6.8 | 9 Jun 2025 | 9 Jun 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 6.7 | 6.7 | 6.7 | 3 Jul 2025 | 3 Jul 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 3 | 6.4 | 5.4 | 7.0 | 14 Jan 2025 | 26 Jan 2026 |
| YimeiCASE #VI-2026-0081 | X | 1 | 6.4 | 6.4 | 6.4 | 17 Dec 2024 | 17 Dec 2024 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 | 24 Apr 2025 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 6.0 | 6.0 | 6.0 | 28 Mar 2025 | 28 Mar 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 5.7 | 5.7 | 5.7 | 2 Jul 2025 | 2 Jul 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 1 | 5.5 | 5.5 | 5.5 | 27 Feb 2025 | 27 Feb 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 5.4 | 5.4 | 5.4 | 14 Jan 2025 | 14 Jan 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 5.4 | 5.4 | 5.4 | 13 Jun 2025 | 13 Jun 2025 |
| TydesCASE #VI-2026-0493 | X | 2 | 5.2 | 5.1 | 5.2 | 6 May 2025 | 19 Jan 2026 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 5.0 | 5.0 | 5.0 | 16 Mar 2025 | 16 Mar 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 4.1 | 4.1 | 4.1 | 13 Jun 2025 | 13 Jun 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 3.9 | 3.9 | 3.9 | 24 Apr 2025 | 24 Apr 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 3.5 | 1.8 | 5.3 | 3 Jul 2025 | 24 May 2026 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 1.0 | 1.0 | 1.0 | 21 May 2025 | 21 May 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 0.0 | 0.0 | 0.0 | 9 Jun 2025 | 9 Jun 2025 |
Open any subject to view the batch-level evidence for Tren Hex alone.